|
Hycult Biotech
anti human tlr2 tl2 1 ![]() Anti Human Tlr2 Tl2 1, supplied by Hycult Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+tlr2+mab/TLR2%2C+Human%2C+mAb+TL2%2E1/pm22843747-58-6-16 Average 90 stars, based on 1 article reviews
anti human tlr2 tl2 1 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Hycult Biotech
mouse toll like receptor tlr 2 ![]() Mouse Toll Like Receptor Tlr 2, supplied by Hycult Biotech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+tlr2+mab/TLR2%2C+Mouse%2FHuman%2C+mAb+T2%2E5/pm16055120-71-18-32 Average 94 stars, based on 1 article reviews
mouse toll like receptor tlr 2 - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Hycult Biotech
исследование tlr2 и tlr3 выполнялось по стандартной методике с использованием моноклональных антител к tlr2-f фирмы «hycult biotech» ![]() исследование Tlr2 и Tlr3 выполнялось по стандартной методике с использованием моноклональных антител к Tlr2 F фирмы «Hycult Biotech», supplied by Hycult Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+tlr2+mab/TLR2%2C+Mouse%2FHuman%2C+mAb+T2%2E5%2C+FITC/10__14341_slash_probl201258613___18-74-0-15 Average 90 stars, based on 1 article reviews
исследование tlr2 и tlr3 выполнялось по стандартной методике с использованием моноклональных антител к tlr2-f фирмы «hycult biotech» - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Hycult Biotech
human tlr2 ![]() Human Tlr2, supplied by Hycult Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+tlr2+mab/TLR2%2C+Human%2C+mAb+TLR2%2E45/pmc05550410-32-7-11 Average 90 stars, based on 1 article reviews
human tlr2 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Hycult Biotech
anti human tlr2 ![]() Anti Human Tlr2, supplied by Hycult Biotech, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+tlr2+mab/TLR2%2C+Human%2C+mAb+TL2%2E3/pm16548886-152-4-12 Average 91 stars, based on 1 article reviews
anti human tlr2 - by Bioz Stars,
2026-11
91/100 stars
|
Buy from Supplier |
|
Novimmune
anti-human tlr-2 mab (t2.5) ![]() Anti Human Tlr 2 Mab (T2.5), supplied by Novimmune, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+tlr2+mab/anti+human+tlr+2+mab++t2+5+/pm19035500-72-21-43 Average 90 stars, based on 1 article reviews
anti-human tlr-2 mab (t2.5) - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Stressgen Biotechnologies
mab human tlr2 (tl2.1 ![]() Mab Human Tlr2 (Tl2.1, supplied by Stressgen Biotechnologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+tlr2+mab/mab+human+tlr2++tl2+1+antibody/pmc02720835-70-11-16 Average 90 stars, based on 1 article reviews
mab human tlr2 (tl2.1 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Bio-Techne corporation
human cd3 epsilon antibody ![]() Human Cd3 Epsilon Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+tlr2+mab/Human+CD3+epsilon+Antibody/custom%40mab100%4020149794 Average 94 stars, based on 1 article reviews
human cd3 epsilon antibody - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
The monoclonal antibody TL2.1 recognizes human Toll-like receptor 2 (TLR2, CD282). Toll-like receptors (TLR) are highly conserved throughout evolution and are involved in the innate defence to many pathogens. In Drosophila toll is required for
|
Buy from Supplier |
|
The monoclonal antibody TL2.1 recognizes human Toll-like receptor 2 (TLR2, CD282). Toll-like receptors (TLR) are highly conserved throughout evolution and are involved in the innate defence to many pathogens. In Drosophila toll is required for
|
Buy from Supplier |
Image Search Results
Journal: International immunology
Article Title: TAK1 contributes to the enhanced responsiveness of LTB(4)-treated neutrophils to Toll-like receptor ligands.
doi: 10.1093/intimm/dxs074
Figure Lengend Snippet: Fig. 1. LTB4 potentiates secretion of IL-8 and TNFα by human neutrophils treated with TLR2 ligand. (A–D) Human neutrophils (5 × 106 cells) were pretreated or not pretreated with LTB4 (100 nM) for 30 min prior to stimulation with increasing concentrations of LTA (A and B) or pretreated or not pretreated with increasing concentrations of LTB4 prior to stimulation with LTA (10 μg ml−1) (C and D) for 6 h. Following stimulation, cell-free supernatants were harvested and tested for the presence of (A and C) IL-8 and (B and D) TNFα by ELISA. Inset in (A) shows that pretreatment with antagonist U75302 (10 μM) abolishes LTB4-induced IL-8 secretion. (E and F) Human neutrophils were treated with LTB4 (100 nM), LTA (10 μg ml−1) alone or pretreated with LTB4 for 30 min before stimulation with LTA for indicated times. Cell-free supernatants were harvested and tested for the presence of IL-8 (E) and TNFα (F). NS, not stimulated. *P ≤ 0.05 as compared with respective samples stimulated with LTA alone.
Article Snippet: Cells were stained with an FITC-conjugated
Techniques: Enzyme-linked Immunosorbent Assay
Journal: International immunology
Article Title: TAK1 contributes to the enhanced responsiveness of LTB(4)-treated neutrophils to Toll-like receptor ligands.
doi: 10.1093/intimm/dxs074
Figure Lengend Snippet: Fig. 3. LTB4 does not increase TLR1, TLR2, TLR4 and TLR6 expression on human neutrophils. (A) Human neutrophils (10 × 106 cells) were stim- ulated with LTB4 (100 nM) for 2 h. Following stimulation, total RNA was extracted and RT–PCR was performed using specific primers for human TLR1, TLR2, TLR4 and TLR6. GAPDH was used as an internal control. (B and C) Human neutrophils (5 × 106 cells) were stimulated with LTB4 (100 nM) for 15, 30, 60 min, 2 and 4 h. TLR2 and TLR4 expression were determined by flow cytometry. Histogram showed is one representative of three different donors. NS, not stimulated.
Article Snippet: Cells were stained with an FITC-conjugated
Techniques: Expressing, Reverse Transcription Polymerase Chain Reaction, Control, Flow Cytometry
Journal: International immunology
Article Title: TAK1 contributes to the enhanced responsiveness of LTB(4)-treated neutrophils to Toll-like receptor ligands.
doi: 10.1093/intimm/dxs074
Figure Lengend Snippet: Fig. 5. TAK1 signaling is essential in LTB4-mediated potenti- ation of TLR2 responses. HEK293 cells were transiently cotrans- fected with human TLR2- and BLT1-expressing vectors. Forty-eight hours post-transfection, cells were transfected with IRAK1- or TAK1-targeting siRNAs. Cells were stimulated with LTA (10 µg ml−1), LTB4 (100 nM) or a combination of both stimuli and IL-8 concentra- tions determined in overnight supernatants. Data are average sam- ples from two different experiments. NS, not stimulated. *P ≤ 0.05 as compared with respective samples without siRNA transfection.
Article Snippet: Cells were stained with an FITC-conjugated
Techniques: Expressing, Transfection
Journal: Frontiers in Cellular and Infection Microbiology
Article Title: Porphyromonas gingivalis Stimulates TLR2-PI3K Signaling to Escape Immune Clearance and Induce Bone Resorption Independently of MyD88
doi: 10.3389/fcimb.2017.00359
Figure Lengend Snippet: Experimental periodontitis induced by oral challenge with P. gingivalis . Groups of mice were administered P. gingivalis in CMC vs. CMC alone by repeated oral gavage. Six weeks later, the maxillae were harvested and alveolar bone volume was measured by μCT from the cemento-enamel junction to a reference line. The residual bone volume of P. gingivalis infected mice was compared to vehicle-treated mice ( n = 8–10 per group). (A) WT, Tlr2 −/− , Myd88 −/− , and Tlr2/Myd88 double knock-out mice (DKO) infected with P. gingivalis ATCC 381. (B) An independent experiment examined bone loss in WT vs. Myd88 −/− mice infected with P. gingivalis ATCC 381 vs. P. gingivalis ATCC 53977. Ns, non-significant. ** P ≤ 0.01, *** P ≤ 0.005.
Article Snippet: T2.5 monoclonal antibody (mAb) against mouse and
Techniques: Infection, Knock-Out
Journal: Frontiers in Cellular and Infection Microbiology
Article Title: Porphyromonas gingivalis Stimulates TLR2-PI3K Signaling to Escape Immune Clearance and Induce Bone Resorption Independently of MyD88
doi: 10.3389/fcimb.2017.00359
Figure Lengend Snippet: Detection of P. gingivalis in mouse tissue following the third oral challenge.
Article Snippet: T2.5 monoclonal antibody (mAb) against mouse and
Techniques:
Journal: Frontiers in Cellular and Infection Microbiology
Article Title: Porphyromonas gingivalis Stimulates TLR2-PI3K Signaling to Escape Immune Clearance and Induce Bone Resorption Independently of MyD88
doi: 10.3389/fcimb.2017.00359
Figure Lengend Snippet: IFN-γ priming enables TLR2-dependent, MYD88-independent signaling in macrophages in response to P. gingivalis challenge. (A) Naïve Myd88 −/− BMM vs. BMM primed with IFN-γ (100 ng/ml) for 2 h were challenged with P. gingivalis (MOI 100) vs. Pam3CSK4 (10 μg/ml). In (B) Myd88 −/− BMM primed with IFN-γ were challenged with increasing MOI of P. gingivalis . (A,B) Supernatants were collected after overnight stimulation and tested for TNF by ELISA. ** P ≤ 0.01, *** P ≤ 0.005.
Article Snippet: T2.5 monoclonal antibody (mAb) against mouse and
Techniques: Enzyme-linked Immunosorbent Assay
Journal: Frontiers in Cellular and Infection Microbiology
Article Title: Porphyromonas gingivalis Stimulates TLR2-PI3K Signaling to Escape Immune Clearance and Induce Bone Resorption Independently of MyD88
doi: 10.3389/fcimb.2017.00359
Figure Lengend Snippet: Kinase involvement in the Myd88 −/− response to P. gingivalis . (A) Ly6C+ BM neutrophils or (B–D) BMM were prepared from Myd88 −/− mice and primed with IFN-γ (100 ng/ml for 2 h). (A,B) Inhibitors for PI3K (LY 2940002 100 μM), p38 MAPK (SB 202190 50 μM), mTORC1 (RaPamycin 60 nM) and RAC1 inhibitor (NSC 23766, 50 μM) were added 30 min before challenge with P. gingivalis (MOI 100). DMSO was used as a control at the highest concentration used in the inhibitor wells. Supernatants were collected after overnight stimulation and the percent inhibition of TNF production is shown. (C) Myd88 −/− BMM were similarly primed and Ly294 was added at increasing concentrations 30 min prior to challenge with P. gingivalis . (D) Myd88 −/− BMM were primed with IFN-γ and antibodies (20 μg/ml anti-TLR2 or TLR4 vs. isotype control, I.C.) or LY294 were added prior to challenge with P. gingivalis . * P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.005.
Article Snippet: T2.5 monoclonal antibody (mAb) against mouse and
Techniques: Concentration Assay, Inhibition
Journal: Frontiers in Cellular and Infection Microbiology
Article Title: Porphyromonas gingivalis Stimulates TLR2-PI3K Signaling to Escape Immune Clearance and Induce Bone Resorption Independently of MyD88
doi: 10.3389/fcimb.2017.00359
Figure Lengend Snippet: TLR2-PI3K plays a non-redundant role in the murine and human macrophage response to P. gingivalis . WT murine BMM (A) , RAW264.7 macrophages (B) , and PMA-differentiated human THP-1 cells (C) were primed with IFN-γ. TLR2 and TLR4 were inhibited with blocking antibodies vs. isotype control (I.C.) for 1 h and PI3K was blocked with LY294 prior to challenge with P. gingivalis (MOI 10). Supernatants were collected after overnight incubation and TNF was measured by ELISA. Background (BG) represents IFN-γ primed cells not challenged with P. gingivalis . Cells challenged with P. gingivalis without any blocker are referred to in the graphs as (–). Representative graphs of >3 repeats are shown. * P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.005.
Article Snippet: T2.5 monoclonal antibody (mAb) against mouse and
Techniques: Blocking Assay, Incubation, Enzyme-linked Immunosorbent Assay
Journal: Frontiers in Cellular and Infection Microbiology
Article Title: Porphyromonas gingivalis Stimulates TLR2-PI3K Signaling to Escape Immune Clearance and Induce Bone Resorption Independently of MyD88
doi: 10.3389/fcimb.2017.00359
Figure Lengend Snippet: TLR2-PI3K signaling suppresses phagocytosis and enhances intracellular survival. (A) RAW264.7 or (B) PMA-differentiated THP-1 cells were treated with blocking antibodies or PI3K inhibitor and then challenged with FITC-labeled P. gingivalis at MOI 10 for 1 h. Cells were then washed, extracellular fluorescence was quenched with trypan blue, and phagocytosis was determined using a fluorescence plate reader (RFU, relative fluorescence units). (C,D) RAW 264.7 cells were treated with TLR blocking antibodies or the PI3K inhibitor prior to challenge with P. gingivalis at MOI 10 for 1 h. Cells were then washed and extracellular bacteria were killed by incubating the cells with Metronidazole and Gentamycin for 1 h. Cells were allowed to recover in fresh media for an additional hour after which they were lysed by DDW for 20 min and lysates were plated on blood agar plates in serial dilution. CFU were enumerated after 7 days of anaerobic growth. * P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.005.
Article Snippet: T2.5 monoclonal antibody (mAb) against mouse and
Techniques: Blocking Assay, Labeling, Fluorescence, Serial Dilution
Journal: Frontiers in Cellular and Infection Microbiology
Article Title: Porphyromonas gingivalis Stimulates TLR2-PI3K Signaling to Escape Immune Clearance and Induce Bone Resorption Independently of MyD88
doi: 10.3389/fcimb.2017.00359
Figure Lengend Snippet: TLR2-PI3K signaling enhances intracellular survival by blocking phago-lysosomal maturation. RAW 264.7 cells were seeded at 3 × 104 cells/ well in Ibidi 8 well m-slides. The cells were untreated (A) or treated with anti-TLR2 (B) , anti-TLR4 (C) , or with the PI3K inhibitor LY 294002 (D) for an hour. Cells were then infected with FITC-labeled P. gingivalis at MOI 10 for 1 h. LysoTracker red was added at 50 nM for the last 10 min of infection. Cells were washed and fixed with 2% formaldehyde and mounted with mounting media. Images were captured using a NIKON confocal microscope at 60X magnification. Yellow color indicates co-localization of P. gingivalis (green) with lysosomes (red). In each field (A–D) the cell in the box is further magnified and shown in the upper right corner. (E) The percent of co-localization was determined by counting cells that demonstrate co-localization as a percentage of all FITC positive cells. (F) Schematic representation of the pathway used by P. gingivalis to evade bactericidal activity without preventing inflammation. *** P ≤ 0.005.
Article Snippet: T2.5 monoclonal antibody (mAb) against mouse and
Techniques: Blocking Assay, Infection, Labeling, Microscopy, Activity Assay